| Q36272396 | Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy |
| Q47184322 | Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in France |
| Q36320998 | Clinical applications of gene-based risk prediction for lung cancer and the central role of chronic obstructive pulmonary disease |
| Q85927339 | Genetic variation in innate immunity and inflammation pathways associated with lung cancer risk |
| Q91912673 | Identification of dynamic signatures associated with smoking-related squamous cell lung cancer and chronic obstructive pulmonary disease |
| Q30239798 | Lung cancer and chronic obstructive pulmonary disease: From a clinical perspective |
| Q35153428 | Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score. |
| Q27336183 | Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: A decision analysis |
| Q46176156 | Reduced Expiratory Flow Rate among Heavy Smokers Increases Lung Cancer Risk. Results from the National Lung Screening Trial-American College of Radiology Imaging Network Cohort |
| Q24201867 | Screening for lung cancer |
| Q90182609 | Sequential screening for lung cancer in a high-risk group: randomised controlled trial: LungSEARCH: a randomised controlled trial of Surveillance using sputum and imaging for the EARly detection of lung Cancer in a High-risk group |